D L Longo|J M Witherspoon - JoVE Visualize

Showing results (151-160 of 400) with videos related to

Pageof 40

Sort By:

Journal of Virology|October 1, 1994

In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophagesW K Kim, Y Tang, J J Kenny, et al.

Journal of the National Cancer Institute|May 2, 1990

Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factorsM A Bookman, P Lardelli, E S Jaffe, et al.

The Journal of Experimental Medicine|November 1, 1988

Essential role of the interleukin 2-interleukin 2 receptor pathway in thymocyte maturation in vivoL Tentori, D L Longo, J C Zuñiga-Pflucker, et al.

The American Journal of Surgical Pathology|February 1, 1993

Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine casesA Zarate-Osorno, L J Medeiros, D W Kingma, et al.

Blood|August 1, 1992

Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivoW J Murphy, J R Keller, C L Harrison, et al.

Cancer|November 1, 1985

Multiple recurrences of acute tumor lysis syndrome in an indolent non-Hodgkin's lymphomaR V Boccia, D L Longo, M L Lieber, et al.

Cancer Treatment Reports|November 1, 1982

Results of a randomized double-blind crossover trial of scopolamine versus placebo administered by transdermal patch for the control of cisplatin-induced emesisD L Longo, M Wesley, D Howser, et al.

The Biochemical Journal|July 25, 1998

Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progressionD Chase, Y Feng, B Hanshew, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1985

Renal involvement in diffuse aggressive lymphomas: results of treatment with combination chemotherapyD B Geffen, R I Fisher, D L Longo, et al.

Blood|July 1, 1986

Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemiaK A Foon, G M Nakano, C A Koller, et al.

Pageof 40

Showing results (151-160 of 400) with videos related to

Sort By:

Pageof 40

Journal of Virology|October 1, 1994

In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophagesW K Kim, Y Tang, J J Kenny, et al.

Journal of the National Cancer Institute|May 2, 1990

Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factorsM A Bookman, P Lardelli, E S Jaffe, et al.

The Journal of Experimental Medicine|November 1, 1988

Essential role of the interleukin 2-interleukin 2 receptor pathway in thymocyte maturation in vivoL Tentori, D L Longo, J C Zuñiga-Pflucker, et al.

The American Journal of Surgical Pathology|February 1, 1993

Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine casesA Zarate-Osorno, L J Medeiros, D W Kingma, et al.

Blood|August 1, 1992

Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivoW J Murphy, J R Keller, C L Harrison, et al.

Cancer|November 1, 1985

Multiple recurrences of acute tumor lysis syndrome in an indolent non-Hodgkin's lymphomaR V Boccia, D L Longo, M L Lieber, et al.

Cancer Treatment Reports|November 1, 1982

Results of a randomized double-blind crossover trial of scopolamine versus placebo administered by transdermal patch for the control of cisplatin-induced emesisD L Longo, M Wesley, D Howser, et al.

The Biochemical Journal|July 25, 1998

Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progressionD Chase, Y Feng, B Hanshew, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1985

Renal involvement in diffuse aggressive lymphomas: results of treatment with combination chemotherapyD B Geffen, R I Fisher, D L Longo, et al.

Blood|July 1, 1986

Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemiaK A Foon, G M Nakano, C A Koller, et al.

Pageof 40